Matthew Caufield
Stock Analyst at HC Wainwright & Co.
(0.63)
# 3,003
Out of 4,479 analysts
64
Total ratings
19.05%
Success rate
-28.7%
Average return
Main Sectors:
12 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FDMT 4D Molecular Therapeutics | Reiterates: Buy | $36 | $21.34 | +68.70% | 12 | Jun 7, 2024 | |
| EYEN Eyenovia | Reiterates: Buy | $12 | $0.68 | +1,667.57% | 10 | May 16, 2024 | |
| OPTN OptiNose | Reiterates: Buy | $5 | $1.05 | +376.19% | 4 | May 15, 2024 | |
| OCUP Ocuphire Pharma | Reiterates: Buy | $20 | $1.59 | +1,157.86% | 8 | May 13, 2024 | |
| PHAT Phathom Pharmaceuticals | Reiterates: Buy | $28 | $10.81 | +159.02% | 4 | May 10, 2024 | |
| HLVX HilleVax | Reiterates: Buy | $28 | $14.42 | +94.17% | 3 | May 10, 2024 | |
| ADVM Adverum Biotechnologies | Reiterates: Buy | $30 | $6.97 | +330.42% | 2 | May 10, 2024 | |
| LYRA Lyra Therapeutics | Downgrades: Neutral | $2 | $0.30 | +573.63% | 5 | May 7, 2024 | |
| ALDX Aldeyra Therapeutics | Reiterates: Buy | $10 | $3.25 | +207.69% | 8 | May 6, 2024 | |
| UBX Unity Biotechnology | Reiterates: Buy | $10 | $1.33 | +651.88% | 4 | Nov 14, 2023 | |
| FN Fabrinet | Reiterates: Buy | $28 | $242.90 | -88.47% | 1 | Aug 22, 2023 | |
| OPT Opthea | Reiterates: Buy | $14 | $1.90 | +636.45% | 3 | Aug 1, 2023 |
4D Molecular Therapeutics
Jun 7, 2024
Reiterates: Buy
Price Target: $36
Current: $21.34
Upside: +68.70%
Eyenovia
May 16, 2024
Reiterates: Buy
Price Target: $12
Current: $0.68
Upside: +1,667.57%
OptiNose
May 15, 2024
Reiterates: Buy
Price Target: $5
Current: $1.05
Upside: +376.19%
Ocuphire Pharma
May 13, 2024
Reiterates: Buy
Price Target: $20
Current: $1.59
Upside: +1,157.86%
Phathom Pharmaceuticals
May 10, 2024
Reiterates: Buy
Price Target: $28
Current: $10.81
Upside: +159.02%
HilleVax
May 10, 2024
Reiterates: Buy
Price Target: $28
Current: $14.42
Upside: +94.17%
Adverum Biotechnologies
May 10, 2024
Reiterates: Buy
Price Target: $30
Current: $6.97
Upside: +330.42%
Lyra Therapeutics
May 7, 2024
Downgrades: Neutral
Price Target: $2
Current: $0.30
Upside: +573.63%
Aldeyra Therapeutics
May 6, 2024
Reiterates: Buy
Price Target: $10
Current: $3.25
Upside: +207.69%
Unity Biotechnology
Nov 14, 2023
Reiterates: Buy
Price Target: $10
Current: $1.33
Upside: +651.88%
Fabrinet
Aug 22, 2023
Reiterates: Buy
Price Target: $28
Current: $242.90
Upside: -88.47%
Opthea
Aug 1, 2023
Reiterates: Buy
Price Target: $14
Current: $1.90
Upside: +636.45%